Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Cell Therapy Market Size & Share to Surpass $27.95 Billion by 2030 | Vantage Market Research

Published

on

<!– Name:DistributionId Value:8808063 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1235589 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:79bd0ea3-b2c5-4c8b-878f-0997d0455dfe –>

WASHINGTON, April 14, 2023 (GLOBE NEWSWIRE) — According to a recent report by Vantage Market Research, the Global Cell Therapy Market size was valued at USD 11.21 Billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 12.10% from 2023 to 2030. The increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and autoimmune disorders, along with the growing geriatric population, are major factors driving the growth of the Cell Therapy Market.

Market Overview

Cell therapy is an innovative field of medicine that uses living cells to treat a variety of diseases and medical conditions. The Global Cell Therapy Market is growing rapidly, with increasing demand for new and effective treatments for chronic diseases and genetic disorders. In this article, we will provide an overview of the Cell Therapy Market, including its current state, growth drivers, and key players.

Get Access to Free Sample Research Report with Latest Industry Insights @ https://www.vantagemarketresearch.com/cell-therapy-market-1236/request-sample

Market Dynamics

  • The increasing prevalence of chronic diseases, such as cancer, heart disease, and diabetes
  • The rising demand for personalized medicine
  • The advances in cell therapy technology
  • The increasing government funding for cell therapy research

Challenges

  • The high cost of cell therapy
  • The lack of regulatory approval for many cell therapies
  • The shortage of qualified cell therapy professionals
  • The potential for side effects

Opportunities and Recommendations

The Cell Therapy Market offers a number of opportunities, including:

  • The potential to treat a wide range of diseases
  • The increasing demand for personalized medicine
  • The advances in cell therapy technology
  • The increasing government funding for cell therapy research

Recommendations for the Cell Therapy Market include:

  • Developing more affordable cell therapies
  • Obtaining regulatory approval for more cell therapies
  • Increasing the number of qualified cell therapy professionals
  • Conducting more research on the safety and efficacy of cell therapies

Top Players in the Global Cell Therapy Market

  • Pharmicell Co. Ltd
  • Corestem Inc.
  • Chiesi Farmaceutici SpA
  • Tegoscience
  • Anterogen Co. Ltd
  • TiGenix (Takeda Pharmaceuticals)
  • Stempeutics Research Pvt Ltd
  • Nipro Corporation
  • Medipost Co. Ltd.

Budget Limitation? Contact us for Special Discount and Pricing

Top Report Findings

  • By cell type, the market is segmented into stem cells, non-stem cells, and progenitor cells. Stem cells are the most promising cell type for cell therapy, as they have the ability to self-renew and differentiate into any type of cell in the body. Non-stem cells and progenitor cells are also used in cell therapy, but they have a more limited range of applications.
  • By therapy type, the market is segmented into autologous therapies, allogenic therapies, and xenogeneic therapies. Autologous therapies use the patient’s own cells, while allogenic therapies use cells from a donor. Xenogeneic therapies use cells from an animal source. Autologous therapies are the most common type of cell therapy, as they are less likely to cause rejection. However, allogenic and xenogeneic therapies have the potential to be more widely available, as they do not require a matching donor.
  • By therapeutic area, the market is segmented into cancer, cardiovascular disease, neurological disorders, autoimmune disorders, and other. Cancer is the largest therapeutic area for cell therapy, as it has the most potential to benefit from the use of cell therapies. Cardiovascular disease, neurological disorders, and autoimmune disorders are also promising therapeutic areas for cell therapy.
  • By end user, the market is segmented into hospitals and clinics, academic and research institutes, and pharmaceutical companies. Hospitals and clinics are the largest end users of cell therapy, as they are the ones who administer cell therapies to patients. Academic and research institutes are also important end users of cell therapy, as they are the ones who conduct research on cell therapies and develop new cell therapies. Pharmaceutical companies are also important end users of cell therapy, as they are the ones who develop and commercialize cell therapies.

Top Trends in Global Cell Therapy Market

  • The increasing use of allogeneic cells – Allogeneic cells are cells that are donated from another person. They are becoming increasingly popular in cell therapy, as they can be used to treat a wider range of diseases than autologous cells (cells that are taken from the patient’s own body).
  • The development of new cell types – Researchers are developing new cell types for cell therapy, including induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs). iPSCs are adult cells that have been reprogrammed to a pluripotent state, meaning they can differentiate into any type of cell in the body. MSCs are a type of stem cell that is found in bone marrow and other tissues. They have the ability to self-renew and differentiate into a variety of cell types.
  • The use of cell therapy for the treatment of cancer – Cell therapy is being increasingly used to treat cancer. One of the most promising approaches is CAR T-cell therapy. CAR T-cells are engineered T cells that have been programmed to recognize and kill cancer cells. CAR T-cell therapy has been shown to be effective in treating a variety of blood cancers, including acute lymphoblastic leukemia (ALL) and B-cell lymphoma.
  • The use of cell therapy for the treatment of other diseases – Cell therapy is also being used to treat a variety of other diseases, including heart disease, diabetes, and neurological disorders. For example, cell therapy is being used to repair damaged heart tissue and to improve blood sugar control in people with diabetes.

Buy this Premium Research Report with Discount | Immediate Delivery @ https://www.vantagemarketresearch.com/buy-now/cell-therapy-market-1236/0

Recent Developments in the Global Cell Therapy Market

  • The bone marrow source segment contributed maximum share in Autologous Cell Therapy Product Market in 2021. Since most of the hematopoietic stem cells and mesenchyme are recovered from the bone marrow and bone marrow is the center for most of the stem cells. The widespread Research and Development (R&D) activities for bone marrow-derived stem cells is expected to boost market growth.
  • Research center End-User segment accounted potential growth for Autologous Cell Therapy Product Market in 2021. There are several donations and investments done to the research facilities by the public sectors & private sectors that are encouraging the segmental growth of Autologous Cell Therapy Product Market.

Browse market data Tables and Figures spread through 187 Pages and in-depth TOC on Cell Therapy Market Forecast Report (2023-2030).

Segmentation of the Global Cell Therapy Market

By Use-Type

  • Clinical Use: This segment includes cell therapies that are used to treat patients. Clinical use cell therapies are typically more expensive than research use cell therapies, as they have undergone more rigorous testing and are regulated by government agencies.
  • Research Use: This segment includes cell therapies that are used for research purposes. Research use cell therapies are typically less expensive than clinical use cell therapies, as they have not undergone as much testing and are not regulated by government agencies.

By Type

  • Autologous Therapies: This segment includes cell therapies that are made from the patient’s own cells. Autologous therapies are typically less risky than allogeneic therapies, as they do not involve the risk of rejection. However, autologous therapies can be more expensive, as they require the patient to undergo a separate procedure to collect their own cells.
  • Allogeneic Therapies: This segment includes cell therapies that are made from cells that are donated from another person. Allogeneic therapies are typically more expensive than autologous therapies, as they involve the risk of rejection. However, allogeneic therapies can be less expensive than autologous therapies, as they do not require the patient to undergo a separate procedure to collect their own cells.

Read Full Report with TOC @ https://www.vantagemarketresearch.com/industry-report/cell-therapy-market-1236

Scope of the Report:    

Report Attributes Details
Market Size in 2022 USD 11.21 Billion
Revenue Forecast by 2030 USD 27.95 Billion
CAGR 12.10 % from 2023 to 2030
Base Year 2022
Forecast Year 2023 to 2030
Key Players Kolon TissueGene, Inc.; Anterogen Co., Ltd.; JCR Pharmaceuticals Co., Ltd.; Castle Creek Biosciences, Inc.; The Future of Biotechnology, MEDIPOST; Osiris Therapeutics, Inc.; PHARMICELL Co., Ltd.; Tameika Cell Technologies, Inc.; Cells for Cells; NuVasive, Inc.; Vericel Corporation; Celgene Corporation, among others.
Customization Request If our report does not include the information you are searching for, you may contact us to have a report tailored to your specific business needs https://www.vantagemarketresearch.com/cell-therapy-market-1236/request-sample

The Global Cell Therapy Market is segmented into five major regions: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

  • North America is the largest market for cell therapy, accounting for a major share of the global market. This is due to the presence of a large number of cell therapy companies and research institutions in the region. Additionally, the regulatory environment in North America is favorable for cell therapy development.
  • Europe is the second largest market for cell therapy. The market in Europe is growing at a rapid pace, due to the increasing prevalence of chronic diseases and the rising demand for personalized medicine. Additionally, the regulatory environment in Europe is favorable for cell therapy development.
  • Asia-Pacific is the third largest market for cell therapy. The market in Asia-Pacific is expected to grow at a rapid pace in the coming years, due to the increasing prevalence of chronic diseases and the rising disposable incomes in the region. Additionally, the regulatory environment in Asia-Pacific is becoming more favorable for cell therapy development.
  • Latin America and Middle East & Africa are the two smallest markets for cell therapy. However, these markets are expected to grow at a rapid pace in the coming years, due to the increasing prevalence of chronic diseases and the rising disposable incomes in the region. Additionally, the regulatory environment in Latin America and Middle East & Africa is becoming more favorable for cell therapy development.

Key Questions Answered in the Cell Therapy Market Report are:

  • What is the Global Cell Therapy Market size?
  • What are the major factors driving the growth of the Global Cell Therapy Market?
  • What are the major challenges facing the Global Cell Therapy Market?
  • What are the major trends in the Global Cell Therapy Market?
  • Which are the leading players in the Global Cell Therapy Market?
  • What are the strategies adopted by the leading players in the Global Cell Therapy Market?

Browse More Reports from Vantage Library:

About Vantage Market Research:        

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies.

Follow Us on: LinkedIn | Twitter | Facebook | YouTube

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 – 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727

Email: [email protected]

Website:

https://www.vantagemarketresearch.com/

Latest Vantage Market Research Press Releases

Latest Vantage Market Research Blog

Vantage Market Research All Reports

Blog:

 

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

US Air Force Awards ThroughPut.ai Direct-to-Phase-II Contract for Boeing, Lockheed Martin, and Sikorsky Mission Design Series to Accelerate Aircraft Readiness

Published

on

us-air-force-awards-throughput.ai-direct-to-phase-ii-contract-for-boeing,-lockheed-martin,-and-sikorsky-mission-design-series-to-accelerate-aircraft-readiness

Leveraging Data to Drive Maintenance-first actions that improve overall supply chain throughput across the DAF.
NEW YORK, May 28, 2024 /PRNewswire/ — ThroughPut.ai, the Supply Chain Decision Intelligence Pioneer, announces it has been selected by AFWERX for a (SBIR Direct-to-Phase II contract) in the amount of $1,248,627.00 focused on “AI-Powered Proactive Supply Chain Capabilities” to address the most pressing challenges in the Department of the Air Force (DAF). The Air Force Research Laboratory and AFWERX have partnered to streamline the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) process by accelerating the small business experience through faster proposal to award timelines, changing the pool of potential applicants by expanding opportunities to small business and eliminating bureaucratic overhead by continually implementing process improvement changes in contract execution. The DAF began offering the Open Topic SBIR/STTR program in 2018 which expanded the range of innovations the DAF funded and now on April 17th, 2024, ThroughPut.ai will start its journey to create and provide innovative capabilities that will strengthen the national defense of the United States of America.

“ThroughPut.ai looks forward to supporting efforts to accelerate inventory flow across the United States Air Force,” said Ali Raza, CEO & Founder of ThroughPut.ai. “By driving inventory/materiel management changes at the maintenance endpoint first, supply chain improvements can then be amplified across the greater industrial base to create aircraft capacity.”
“The views expressed are those of the author and do not necessarily reflect the official policy or position of the Department of the Air Force, the Department of Defense, or the U.S. government.”
About (ThroughPut.ai)
ThroughPut.ai is a Silicon Valley-based supply chain optimization & predictive replenishment company. The company’s software AI platform has the ability to identify location-, product-, and customer-based demand changes sooner in order to adjust order frequencies, vendor sources, and parts buffer levels at a global and local scale. ThroughPut’s platform was designed by Fortune 500 & technology executives with real-world experience managing demand & supply chain disruptions and war-zone logistics across the Middle East.
About AFRLThe Air Force Research Laboratory is the primary scientific research and development center for the Department of the Air Force. AFRL plays an integral role in leading the discovery, development, and integration of affordable warfighting technologies for our air, space and cyberspace force. With a workforce of more than 12,500 across nine technology areas and 40 other operations across the globe, AFRL provides a diverse portfolio of science and technology ranging from fundamental to advanced research and technology development. For more information, visit afresearchlab.com.
About AFWERXAs the innovation arm of the DAF and a directorate within the Air Force Research Laboratory, AFWERX brings cutting-edge American ingenuity from small businesses and start-ups to address the most pressing challenges of the DAF. AFWERX employs approximately 370 military, civilian and contractor personnel at five hubs and sites executing an annual $1.4 billion budget. Since 2019, AFWERX has executed over 6,100 new contracts worth more than $4 billion to strengthen the U.S. defense industrial base and drive faster technology transition to operational capability. For more information, visit: www.afwerx.com. 
Company Press Contact:Ali RazaCEO/[email protected] 

View original content:https://www.prnewswire.co.uk/news-releases/us-air-force-awards-throughputai-direct-to-phase-ii-contract-for-boeing-lockheed-martin-and-sikorsky-mission-design-series-to-accelerate-aircraft-readiness-302156930.html

Continue Reading

Artificial Intelligence

Data Center Investments Soar: 200% Rise Since 2016 and Projected 89% Increase by 2028

Published

on

data-center-investments-soar:-200%-rise-since-2016-and-projected-89%-increase-by-2028

USA News Group CommentaryIssued on behalf of Avant Technologies Inc.
VANCOUVER, BC, May 28, 2024 /PRNewswire/ — Since 2016, investment in data centre infrastructure has risen 200%, with a further 89% increase expected by 2028 as more opportunities emerge with the rise of artificial intelligence (AI). According to Jones Lang LaSalle Inc.’s CEO Christian Ulbrich, data centers are “the hottest asset class at the moment.” Analysts at Technavio are projecting the global data center market to record an additional US$329.82 billion in growth at a CAGR of 12.73% through 2027. Capitalizing on the opportunity are several players recently announcing developments regarding their involvement in the data centers sector, including

Avant Technologies Inc. (OTCQB: AVAI), Amazon.com, Inc. (NASDAQ: AMZN), Applied Digital Corporation (NASDAQ: APLD), Digital Realty Trust, Inc. (NYSE: DLR), and Equinix, Inc. (NASDAQ: EQIX).
As an early pioneer in generative AI, Avant Technologies Inc. (OTCQB: AVAI) continues to enhance its flagship asset, Avant AITM, a sophisticated machine and deep learning AI system designed for versatility and customization across various industries and applications. Recently, Avant announced plans to equip its AI-managed data center, currently in development, with High-Performance Computing (HPC) systems. According to IBM, HPC technology utilizes clusters of powerful processors working in parallel to process massive multi-dimensional data sets and solve complex problems at exceptionally high speeds.
“The rise of AI is revolutionizing industries, and Avant Technologies is committed to being at the forefront of this transformation,” said William Hisey, CEO of Avant. “By building an AI-managed data center with HPC systems, we will gain the computational power and infrastructure required to train and deploy sophisticated AI models, which will ultimately provide even greater value to our customers.”
The new data center will leverage AI-driven management technology to optimize resource allocation and enhance efficiency in all aspects of data center operations. Avant will meticulously design its HPC infrastructure to meet the demands of AI workloads, selecting high-performance CPUs and GPUs (or TPUs) specifically suited for deep learning tasks. This cutting-edge facility will enable Avant to accelerate AI advancements, delivering innovative solutions to clients by improving data center efficiency and empowering them with exceptional AI capabilities.
Additionally, Avant will implement a high-speed network to ensure efficient data transfer and select a scalable storage solution to manage the large datasets necessary for training and utilizing AI models. The HPC systems will prioritize security, incorporating robust measures to protect sensitive data and create a secure environment for AI deployment. Furthermore, the data center will integrate energy-efficient technologies and sustainable design practices, reflecting Avant’s commitment to environmental responsibility.
Avant Technologies also recently announced plans to implement AI-empowered Zero Trust Architecture (ZTA) across its data center operations. Additionally, the company has expanded its AvantAI™ platform to include intelligent, proactive monitoring and management for data centers.
Over the past few weeks Amazon.com, Inc. (NASDAQ: AMZN) has collectively committed to investing $20 billion into new data centers for its subsidiary Amazon Web Services (AWS). The first to be announced was an $11-billion data center to be built in Indiana, with another $9 billion set to accelerate cloud-infrastructure in Singapore. The moves fall in line with Amazon CEO Andy Jassy’s projection that 85% of IT spending will remain on premises, in the race for Gen AI supremacy.
Amazon also recently announced an extension on its partnership between AWS and CrowdStrike to unify cybersecurity protection on its CrowdStrike Falcon platform. As per the agreement, Amazon is replacing a variety of cloud point products with Falcon Cloud Security, is using Falcon Next-Gen SIEM to secure big data logging and is deploying Identity Threat Detection and Response to prevent identity-based attacks.
“CrowdStrike and AWS have a deep history of working together to secure the most innovative companies in the world,” said CJ Moses, Chief Information Security Officer and Vice President of Security Engineering at Amazon. “Amazon uses CrowdStrike to provide visibility, detection, and response across our businesses in order to protect the cloud, infrastructure, and services for our customers. This is part of our shared mission to help all organizations build, operate, and secure their business.”
In a move to shore-up its market position as a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance Computing (“HPC”) applications, Applied Digital Corporation (NASDAQ: APLD) recently announced the appointment of industry veteran Todd Gale as its new Chief Development Officer. The announcement came just one month after the company announced it had issued a $50 million unsecured convertible debenture to advance its HPC Data Center Project in Ellendale, North Dakota.
“We intend to use the net proceeds from the private financing, supplemented by the proceeds from our announced sale of the Garden City facility, to finance substantial advancements in our construction phase of the HPC data center in Ellendale, North Dakota,” said David Rench, CFO of Applied Digital. “Concurrently, we continue negotiating our project-level financing to ensure timely project completion and fulfillment of our contractual obligations.”
Applied Digital intends to utilize chipmaking giant NVIDIA’s new Blackwell platform into its cloud offerings. The company’s next-generation data center campuses are specifically designed to host HPC/AI applications, offering more cost-effective and efficient alternatives to traditional data centers.
In Japan, Digital Realty Trust, Inc. (NYSE: DLR) recently announced the expansion of its NRT Campus, by commencing construction of its third data center to support AI. Upon completion of the site in late 2025, the campus’s capacity will rise to 104MW, with the intention of meeting rising demand for next-generation infrastructure, and seamless access to Japan’s connected data communities.
“Japan’s rapidly increasing demand for AI deployments creates the need for scalable, flexible, and highly connected AI-ready data centers in the Tokyo metropolitan area,” said Serene Nah, Managing Director and Head of Asia Pacific, Digital Realty. “We believe NRT14’s next-generation data center infrastructure and Digital Realty’s connected global open data center platform provide the foundational pillars our customers need to drive innovation in the coming years.”
Equinix, Inc. (NASDAQ: EQIX), another digital infrastructure company, has recently launched a $600 million joint venture with PGIM Real Estate to develop and operate the first xScale data center in the US, situated in California’s Silicon Valley. This follows their successful collaboration on the first xScale data center in Australia in 2022, which was part of a similar $575 million joint venture announced in 2021.
Under the terms of the new agreement, PGIM Real Estate will hold an 80% equity interest in the joint venture, while Equinix will retain a 20% equity stake. xScale data centers by Equinix enable hyperscale companies to expand their core deployments within Equinix’s IBX data centers, facilitating growth in over 70 global metros through a platform that supports direct interconnections with more than 10,000 customers.
This joint venture complements Equinix’s existing hyperscale collaborations in Europe, Asia-Pacific, and the Americas, significantly enhancing the global xScale data center portfolio. Once completed, this global expansion is set to exceed $8 billion, encompassing more than 35 facilities and providing over 725 megawatts of power capacity.
Source: https://usanewsgroup.com/2023/10/26/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/ 
CONTACT:USA NEWS [email protected](604) 265-2873
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased as a part of a private placement. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through further private placements and/or investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

View original content:https://www.prnewswire.co.uk/news-releases/data-center-investments-soar-200-rise-since-2016-and-projected-89-increase-by-2028-302156928.html

Continue Reading

Artificial Intelligence

Lucinity Wins the Microsoft Partner Awards for 2024 for Partner of the Year – Iceland and Sustainability and Social Impact

Published

on

lucinity-wins-the-microsoft-partner-awards-for-2024-for-partner-of-the-year-–-iceland-and-sustainability-and-social-impact

REYKJAVÍK, Iceland, May 28, 2024 /PRNewswire/ — Lucinity, a leading AI company for financial crime prevention, won two awards at the Microsoft Partner Awards for 2024, including Partner of the Year – Iceland and Sustainability and Social Impact, highlighting Lucinity’s innovations and contribution to positive societal change. 

“Congratulations to Lucinity for being recognized as the Partner of the Year – Iceland 2024! Lucinity is leading digital transformation and delivering innovative products in their domain,” says Microsoft’s leadership.
“For the past year, they have played a key role with their offerings, skilled resources, and their ability to drive change and innovative solutions both locally in Iceland and across the globe. Lucinity has had significant social impact and growth while supporting our joint customers in their AI-transformation journeys.”
In June 2023, Lucinity launched the world’s first copilot for FinCrime prevention powered by Microsoft Azure OpenAI called Luci. Luci stands out in the financial services industry with specialized skills for FinCrime prevention such as adverse media checks, case analysis, and SAR writing. 
Built on the robust and scalable Microsoft Azure platform, Lucinity offers customers a trusted SaaS product. Additionally, Lucinity’s presence on the Microsoft Azure Marketplace allows companies to leverage their Microsoft Azure credits to access the platform. 
The seamless integration with Microsoft’s Azure stack has enabled Lucinity to implement advanced AI capabilities, fostering rapid innovation and enabling banks and fintech companies to utilize AI securely and audibly. Furthermore, Luci significantly reduces investigation times from 2.5 hours to just 25 minutes, saving Tier 1 banks an estimated $25 million annually.
Guðmundur Kristjánsson (GK), Lucinity’s Founder and CEO comments, “These awards are a testament to the strength and reliability of our solutions, made possible by our strategic partnership with Microsoft. Utilizing Microsoft Azure, we have been able to drive rapid innovation and create a robust, scalable platform that meets the rigorous requirements of compliance teams.” 
On the Sustainability and Social Impact Partner Award, Microsoft says, “Lucinity, with their innovative AI solutions, has really tried to combat this huge global challenge. They use ‘Human AI’ to enhance financial crime prevention, combining AI with human expertise for efficient, user-friendly solutions. Additionally, Lucinity has developed a tool called Luci, an AI-powered copilot that helps transform financial crime prevention from a process that took hours to one that takes minutes.”
Logo: https://mma.prnewswire.com/media/2208676/4669079/Lucinity_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/lucinity-wins-the-microsoft-partner-awards-for-2024-for-partner-of-the-year—iceland-and-sustainability-and-social-impact-302156888.html

Continue Reading

Trending